MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract
science forward company developing infusion and delivery technologies, this
morning announced the full integration of Lelantos Biotech into MCTC. The
company also provided an operational and product introduction update. MCTC
announced the acquisition of Lelantos Biotech, Inc. in mid-February. Lelantos
Biotech had previously been involved in various areas of cannabinoid and hemp
infusion research and had closely collaborated with MCTC in relation to the
filing of several patents in numerous hemp extract and cannabinoid delivery
technologies. All the developments generated from this collaboration have been
assigned to MCTC, and the rights to all six patent pending technologies belong
to MCTC. Among other highlights, the update also included further information
regarding the integration of the Lelantos technologies, the company’s latest
Hemp You Can Feel(TM) products, and the completion of phase one of its Project
Varin. “We have now integrated the Lelantos technologies and trade secrets into
MCTC Holdings,” MCTC Holdings CEO Arman Tabatabaei stated in the news release.
“The manner in which Lelantos was acquired was particularly
shareholder-friendly with the owners agreeing to take long term notes in
exchange for all of the IP and all rights to the technology. We are now
actively integrating these unique and patent pending technologies into several
products to be marketed under the Hemp You Can Feel(TM) brand. In all, Lelantos
has provided the core technologies allowing us to now have six patents pending.
We plan an active announcement and product introduction calendar as we continue
to create new products based on these innovations.”
To view the full press release, visit http://ibn.fm/c93bf
About MCTC Holdings, Inc.
MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware
registered, fully reporting and audited publicly-traded company. With the hemp
and cannabis industries moving very quickly and with a growing number of market
entrants, MCTC plans to concentrate its efforts on the middle portions of the
hemp and cannabis value chain. The company plans to actively pursue R&D
programs and productization for exotic cannabinoid isolation, bioenhancement of
cannabinoids and polymeric solid nanoparticles and nanofibers for addition into
consumer products and for dermal application. The company was reorganized
during June of 2019 and announced its intent to enter the fast-growing cannabis
sector and its intent to change its corporate identity to Cannabis Global, Inc.
The company is headed and managed by a group of highly experienced cannabis
industry pioneers and entrepreneurs. For more information, visit the company’s
website at www.CannabisGlobalinc.com.
NOTE TO INVESTORS: The latest news and updates
relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment